内部人交易雷达

美国 · SEC Form 4 · 快照日期: 2026-10-18 · 构建时间: 2026-10-18 · English

← 美国市场 · 覆盖记录

美国 · SEC FORM 4

CHEMED CORP

CHE · NYSE · CIK 0000019584 · Healthcare · Medical Care Facilities

内部人信号

当前没有活跃买入信号

0 qualifying P purchase groups
当前 180 天评分窗口

27 同一窗口内观察到的 Form 4 交易行
10 sales · 17 期权、代扣税、授予、赠与或其他交易行

最近一次合资格买入2025-08-04 · WALSH GEORGE J III · $83.4K

为什么没有活跃信号?

买入活动无
近期买入无
近期卖出中等
买入信号状态未激活
评分构成

活跃窗口内没有合资格买入,因此不计算分数。缺失的输入不会被当作零分或看空信号。

Cluster未计算
买入规模未计算
角色未计算
近期性未计算
确信度未计算

为什么没有分数?

  • 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
  • 卖出及其他 Form 4 活动继续作为背景显示,不会形成负分。

卖出和其他 Form 4 活动会单独显示,不会形成负面买入信号。没有买入不会被评分为看空。

内部人活动时间轴

申报人轨道展示最近 180 天。符号形状区分交易类型;卖出仅作为背景。

AprMayJunJulAugSepOct
MCNAMARA KEVIN Jpresident and CEO
▼○○▼▼▼▼
GRACE PATRICK PDirector
▼○▼
LEE SPENCER Sexecutive vice president
▼○○
LINDELL ANDREA RDirector
○▼
WALSH GEORGE J IIIDirector
○▼
HUTTON THOMAS Cvice president
○○
● 买入▼ 卖出○ 其他

Showing the six most active owners; 6 additional owner(s) remain in Form 4 申报证据.

买方广度、集中度与聚集买入

合资格买入进入 180 天研究窗口后,这些模块才会启用。

信号历史

暂无已记录的活跃信号快照

Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2025-08-04 · WALSH GEORGE J III.

近期 Form 4 活动

0买入
13卖出
37其他 Form 4 交易行
32SEC 申报 · 365天
买入0 qualifying P line(s) · 180 days
卖出10 sale line(s) · 仅供背景
其他17 exercise / withholding / award / gift / other lines
10b5-1/计划交易Not assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

市场背景

市场背景补充近期价格表现与风险信息,不影响内部人信号。

价格表现

1M
-2.5%
3M
+5.2%
6M
+33.9%
12M
—

波动率与流动性

波动率
29.1%
Beta
0.51
平均每日成交额
USD 81.5M

估值

市值
USD 6.6B
P/E
25.5×

基本面

利润率
0.0%
ROE
0.0%
细分行业
Medical Care Facilities

市场数据

价格数据截至:2026-09-30 · 价格来源:OpenBB/yfinance · 来自 SEC 申报文件:利润率, ROE · 财年截止日:2025-12-31 · 来自 Yahoo Finance:市值, P/E · Status: PASS

空头余额

空头余额是券商向 FINRA 申报的外部背景数据,不影响内部人信号。

空头股数
596,751
上期报告
653,250
日均成交量
182,103
回补天数
3.3

FINRA 结算日:2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数,每月两个结算日之后约一周公布;不是占已发行股份的比例。

历史股票买入

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting owner类型证券股数平均价格估算金额来源
2025-08-04WALSH GEORGE J III买入 (P)Capital Stock200USD 417.10USD 83,420SEC 申报 ↗
2024-12-30Judkins Brian C买入 (P)Capital Stock145USD 519.50USD 75,328SEC 申报 ↗
2022-12-30WALSH GEORGE J III买入 (P)capital stock4USD 509.34USD 2,037SEC 申报 ↗
2021-12-31SAUNDERS DONALD E买入 (P)capital stock40USD 531.29USD 21,252SEC 申报 ↗
2021-12-31Judkins Brian C买入 (P)capital stock1USD 531.29USD 531SEC 申报 ↗
2020-05-11SAUNDERS DONALD E买入 (P)capital stock49USD 431.60USD 21,148SEC 申报 ↗

Form 4 申报证据

50 transaction lines in the latest 365-day window; 465 in local history.

日期申报人类型证券股数平均价格估算金额来源
2026-09-30LEE SPENCER S期权行权/转换 (M)Capital Stock12,099USD 445.35USD 5,388,290SEC 申报 ↗
2026-09-30LEE SPENCER S代扣税 (F)Capital Stock11,160USD 508.93USD 5,679,659SEC 申报 ↗
2026-09-28MCNAMARA KEVIN J卖出 (S)Capital Stock2,000USD 513.45USD 1,026,900SEC 申报 ↗
展开近期 Form 4 证据 (30 grouped rows)
日期申报人类型证券股数平均价格估算金额来源
2026-09-30LEE SPENCER S期权行权/转换 (M)Capital Stock12,099USD 445.35USD 5,388,290SEC 申报 ↗
2026-09-30LEE SPENCER S代扣税 (F)Capital Stock11,160USD 508.93USD 5,679,659SEC 申报 ↗
2026-09-28MCNAMARA KEVIN J卖出 (S)Capital Stock2,000USD 513.45USD 1,026,900SEC 申报 ↗
2026-09-28HUTTON THOMAS C期权行权/转换 (M)Capital Stock4,629USD 445.35USD 2,061,525SEC 申报 ↗
2026-09-28HUTTON THOMAS C代扣税 (F)Capital Stock4,270USD 506.65USD 2,163,396SEC 申报 ↗
2026-09-18MCNAMARA KEVIN J卖出 (S)Capital Stock2,000USD 501.40USD 1,002,800SEC 申报 ↗
2026-08-21MCNAMARA KEVIN J卖出 (S)Capital Stock2,000USD 541.16USD 1,082,320SEC 申报 ↗
2026-08-21LEE SPENCER S卖出 (S)Capital Stock1,000USD 541.04USD 541,040SEC 申报 ↗
2026-08-10Judkins Brian C期权行权/转换 (M)Capital Stock6,786USD 445.35USD 3,022,145SEC 申报 ↗
2026-08-10Judkins Brian C代扣税 (F)Capital Stock5,878USD 548.96USD 3,226,787SEC 申报 ↗
2026-08-05Wherley Joel L期权行权/转换 (M)Capital Stock2,599USD 445.35USD 1,157,465SEC 申报 ↗
2026-08-05Wherley Joel L代扣税 (F)Capital Stock2,270USD 542.62USD 1,231,747SEC 申报 ↗
2026-08-03MCNAMARA KEVIN J卖出 (S)Capital Stock2,000USD 539.51USD 1,079,020SEC 申报 ↗
2026-07-31MCNAMARA KEVIN J期权行权/转换 (M)Capital Stock2,001USD 445.35USD 891,145SEC 申报 ↗
2026-07-31MCNAMARA KEVIN J代扣税 (F)Capital Stock19,802USD 529.22USD 10,479,614SEC 申报 ↗
2026-07-31GRACE PATRICK P卖出 (S)Capital Stock190USD 532.00USD 101,080SEC 申报 ↗
2026-06-09LINDELL ANDREA R卖出 (S)Capital Stock1,347USD 447.33USD 602,554SEC 申报 ↗
2026-05-29WALSH GEORGE J III卖出 (S)Capital Stock500USD 437.83USD 218,915SEC 申报 ↗
2026-05-18WALSH GEORGE J III奖励/授予 (A)Capital Stock386USD 440.77USD 170,137SEC 申报 ↗
2026-05-18Mount John Meredith Jr.奖励/授予 (A)Capital Stock386USD 440.77USD 170,137SEC 申报 ↗
2026-05-18McCarthy Eileen P奖励/授予 (A)Capital Stock386USD 440.77USD 170,137SEC 申报 ↗
2026-05-18LINDELL ANDREA R奖励/授予 (A)Capital Stock386USD 440.77USD 170,137SEC 申报 ↗
2026-05-18Heaney Christopher J奖励/授予 (A)Capital Stock386USD 440.77USD 170,137SEC 申报 ↗
2026-05-18GRACE PATRICK P奖励/授予 (A)Capital Stock386USD 440.77USD 170,137SEC 申报 ↗
2026-05-18DeLyons Ron奖励/授予 (A)Capital Stock386USD 440.77USD 170,137SEC 申报 ↗
2026-05-08GRACE PATRICK P卖出 (S)Capital Stock60USD 425.78USD 25,547SEC 申报 ↗
2026-05-01MCNAMARA KEVIN J卖出 (S)Capital Stock2,000USD 421.13USD 842,260SEC 申报 ↗
2026-03-27MCNAMARA KEVIN J卖出 (S)Capital Stock1,500USD 369.37USD 554,055SEC 申报 ↗
2026-03-12MCNAMARA KEVIN J卖出 (S)Capital Stock2,000USD 403.18USD 806,360SEC 申报 ↗
2026-02-13Witzeman Michael D期权行权/转换 (M)Capital Stock413USD 469.56USD 193,928SEC 申报 ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

快照与身份

快照日期2026-10-18
排名版本US-v1.2
数据质量PASS ELIGIBLE · —
股票代码CHE
CIK0000019584
行业Healthcare
细分行业Medical Care Facilities Yahoo Finance
SEC SIC8082 Services-Home Health Care Services
交易所NYSE

数据覆盖

本地 Form 4 历史465 transaction lines from 2020-01-06 to 2026-09-30
6 P purchase lines · 135 S sale lines · 324 other lines
SEC 公司申报打开 SEC 申报 ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.